Zuo Z, Yue J, Dong B, Wu T, Liu G, Hao Q
Cochrane Database Syst Rev. 2021; 4:CD004437.
PMID: 33857326
PMC: 8092433.
DOI: 10.1002/14651858.CD004437.pub6.
Yilmazel Ucar E
Eurasian J Med. 2019; 51(2):186-190.
PMID: 31258361
PMC: 6592452.
DOI: 10.5152/eurasianjmed.2019.19291.
Hao Q, Dong B, Yue J, Wu T, Liu G
Cochrane Database Syst Rev. 2018; 12:CD004437.
PMID: 30560579
PMC: 6516871.
DOI: 10.1002/14651858.CD004437.pub5.
Kline J, Hall C, Jones A, Puskarich M, Mastouri R, Lahm T
Am Heart J. 2017; 186:100-110.
PMID: 28454823
PMC: 5412723.
DOI: 10.1016/j.ahj.2017.01.011.
Schlesselman J
J R Soc Med. 2016; 109(1):27-35.
PMID: 26801994
PMC: 4724775.
DOI: 10.1177/0141076815621243.
Computed tomography pulmonary embolism residua index (CTPER-index): a simple tool for pulmonary embolism residua description.
Vavera Z, Elias P, Ryska P, Vojacek J
Anatol J Cardiol. 2015; 16(4):270-5.
PMID: 26642467
PMC: 5368437.
DOI: 10.5152/akd.2015.6178.
Fibrinolysis for Acute Care of Pulmonary Embolism in the Intermediate Risk Patient.
Meyer G, Planquette B, Sanchez O
Curr Atheroscler Rep. 2015; 17(12):68.
PMID: 26486512
DOI: 10.1007/s11883-015-0546-1.
Close concordance between pulmonary angiography and pathology in a canine model with chronic pulmonary thromboembolism and pathological mechanisms after lung ischemia reperfusion injury.
Deng C, Wu D, Zhai Z, Lin Q, Zhong Z, Yang Y
J Thromb Thrombolysis. 2015; 41(4):581-91.
PMID: 26286518
PMC: 4819541.
DOI: 10.1007/s11239-015-1268-5.
The value of electrocardiographic abnormalities in the prognosis of pulmonary embolism: a consensus paper.
Digby G, Kukla P, Zhan Z, Pastore C, Piotrowicz R, Schapachnik E
Ann Noninvasive Electrocardiol. 2015; 20(3):207-23.
PMID: 25994548
PMC: 6931801.
DOI: 10.1111/anec.12278.
Thrombolysis in patients with pulmonary embolism and elevated heart-type fatty acid-binding protein levels.
Gul E, Can I, Kayrak M, Abdulhalikov T, Erdogan H, Altunbas G
J Thromb Thrombolysis. 2013; 37(4):483-9.
PMID: 24264959
DOI: 10.1007/s11239-013-1008-7.
Endovascular treatment of venous occlusive disease.
Kolbel T, Gottsater A, Kuhme T, Lindh M, Ivancev K
Ann Vasc Dis. 2013; 1(2):91-101.
PMID: 23555345
PMC: 3595726.
DOI: 10.3400/avd.AVDrev07022.
The rate of resolution of clot burden measured by pulmonary CT angiography in patients with acute pulmonary embolism.
Aghayev A, Furlan A, Patil A, Gumus S, Jeon K, Park B
AJR Am J Roentgenol. 2013; 200(4):791-7.
PMID: 23521450
PMC: 3646369.
DOI: 10.2214/AJR.12.8624.
Mechanical interventions and thrombolytic therapy in venous thrombosis and pulmonary embolism.
Subramanian R, White C
Ochsner J. 2012; 4(1):30-6.
PMID: 22822312
PMC: 3399236.
Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Kearon C, Akl E, Comerota A, Prandoni P, Bounameaux H, Goldhaber S
Chest. 2012; 141(2 Suppl):e419S-e496S.
PMID: 22315268
PMC: 3278049.
DOI: 10.1378/chest.11-2301.
Inferior vena cava filters.
Kinney T
Semin Intervent Radiol. 2011; 23(3):230-9.
PMID: 21326769
PMC: 3036373.
DOI: 10.1055/s-2006-948760.
Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline.
Mehta S, Helmersen D, Provencher S, Hirani N, Rubens F, de Perrot M
Can Respir J. 2010; 17(6):301-34.
PMID: 21165353
PMC: 3006154.
DOI: 10.1155/2010/704258.
Effect of body mass index on bleeding frequency and activated partial thromboplastin time in weight-based dosing of unfractionated heparin: a retrospective cohort study.
Bauer S, Ou N, Dreesman B, Armon J, Anderson J, Cha S
Mayo Clin Proc. 2009; 84(12):1073-8.
PMID: 19955244
PMC: 2787393.
DOI: 10.4065/mcp.2009.0220.
Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure.
Kline J, Steuerwald M, Marchick M, Hernandez-Nino J, Rose G
Chest. 2009; 136(5):1202-1210.
PMID: 19542256
PMC: 2818852.
DOI: 10.1378/chest.08-2988.
Improving adjunctive treatment in pulmonary embolism and fibrinolytic therapy. The role of enoxaparin and weight-adjusted unfractionated heparin.
Jerjes-Sanchez C, Villarreal-Umana S, Ramirez-Rivera A, Garcia-Sosa A, Miguel-Canseco L, Archondo T
J Thromb Thrombolysis. 2008; 27(2):154-62.
PMID: 18204981
DOI: 10.1007/s11239-008-0192-3.
Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II.
Stein P, Beemath A, Matta F, Weg J, Yusen R, Hales C
Am J Med. 2007; 120(10):871-9.
PMID: 17904458
PMC: 2071924.
DOI: 10.1016/j.amjmed.2007.03.024.
